tiprankstipranks
Trending News
More News >
Sunshine Biopharma (SBFM)
NASDAQ:SBFM
US Market

Sunshine Biopharma (SBFM) Income Statement

Compare
423 Followers

Sunshine Biopharma Income Statement

Last quarter (Q2 2025), Sunshine Biopharma's total revenue was $9.41M, an increase of 1.15% from the same quarter last year. In Q2, Sunshine Biopharma's net income was $-1.77M. See Sunshine Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 34.87M$ 24.09M$ 4.35M$ 228.43K$ 71.41K
Gross Profit
$ 10.67M$ 8.34M$ 1.70M$ 110.60K$ 45.56K
Operating Expenses
$ 16.48M$ 13.12M$ 10.37M$ 2.55M$ 622.44K
Depreciation and Amortization
$ 223.53K$ 149.15K$ 25.16K$ 12.74K$ 14.07K
EBITDA
$ -5.15M$ -3.82M$ -26.45M$ -12.10M$ -2.60M
Operating Income
$ -5.81M$ -4.79M$ -27.00M$ -2.44M$ -576.87K
Other Income/Expenses
$ 443.15K$ 674.42K$ 489.61K$ -10.00M$ -2.21M
Pretax Income
$ -5.37M$ -4.11M$ -26.51M$ -12.44M$ -2.78M
Net Income
$ -5.13M$ -4.51M$ -26.74M$ -12.44M$ -2.78M
Per Share Metrics
Basic EPS
$ -7.32$ -351.36$ -3.52K$ -9.77K$ -3.21K
Diluted EPS
$ -7.32$ -351.36$ -3.52K$ -9.52K$ -3.21K
Weighted Average Shares Outstanding
701.75K 12.16K 7.59K 1.31K 866.00
Weighted Average Shares Outstanding (Diluted)
701.75K 12.16K 7.59K 1.31K 866.00
Currency in USD

Sunshine Biopharma Earnings and Revenue History